Tilray Brands (NASDAQ: TLRY)
Tilray Brands Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Tilray Brands Company Info
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
News & Analysis
This 1 Metric Shows Why You Should Be Cautious With Tilray Brands Stock
Tilray's CEO Makes a Bold Prediction: Is the Stock a Buy?
Could Tilray Brands Be The Next Hims & Hers Health?
If You'd Invested $1,000 in Tilray Stock 6 Years Ago, Here's How Much You'd Have Today
Down 40% This Year, Is Tilray Brands Stock Due for a Much Better Performance in 2025?
Is Tilray Brands Stock a Buy?
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
These 2 Marijuana Stocks Could Surge Under Trump's Second Term
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.